Nifty
Sensex
:
:
23465.60
76992.77
66.70 (0.29%)
181.87 (0.24%)

Pharmaceuticals & Drugs - Global

Rating :
43/99

BSE: 506197 | NSE: BLISSGVS

105.85
14-Jun-2024
  • Open
  • High
  • Low
  • Previous Close
  •  105.75
  •  108.40
  •  104.95
  •  105.37
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  407985
  •  433.38
  •  149.60
  •  75.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,111.76
  • 14.73
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 983.95
  • 0.47%
  • 1.15

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 34.97%
  • 7.28%
  • 31.71%
  • FII
  • DII
  • Others
  • 14.74%
  • 6.59%
  • 4.71%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.11
  • -3.51
  • 9.20

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.12
  • -5.74
  • 1.93

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.62
  • -10.55
  • 1.14

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.97
  • 14.93
  • 15.39

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.10
  • 1.43
  • 1.12

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.82
  • 7.51
  • 6.37

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
198.13
184.78
7.22%
200.72
205.72
-2.43%
211.88
172.43
22.88%
159.52
188.66
-15.45%
Expenses
169.78
178.54
-4.91%
157.03
158.03
-0.63%
157.51
147.88
6.51%
135.31
149.81
-9.68%
EBITDA
28.35
6.24
354.33%
43.69
47.69
-8.39%
54.37
24.55
121.47%
24.21
38.85
-37.68%
EBIDTM
14.31%
3.38%
21.77%
23.18%
25.66%
14.23%
15.18%
20.59%
Other Income
5.60
2.98
87.92%
5.42
5.65
-4.07%
12.60
2.15
486.05%
5.11
7.01
-27.10%
Interest
1.85
5.08
-63.58%
2.12
1.26
68.25%
1.45
1.91
-24.08%
1.49
2.11
-29.38%
Depreciation
6.85
4.88
40.37%
6.95
4.64
49.78%
6.39
4.60
38.91%
6.19
4.55
36.04%
PBT
-3.95
-0.75
-
40.04
47.43
-15.58%
59.13
20.19
192.87%
21.65
39.20
-44.77%
Tax
0.97
-4.22
-
10.97
17.64
-37.81%
16.09
4.19
284.01%
7.27
11.72
-37.97%
PAT
-4.91
3.47
-
29.07
29.79
-2.42%
43.04
16.00
169.00%
14.38
27.48
-47.67%
PATM
-2.48%
1.88%
14.48%
14.48%
20.32%
9.28%
9.01%
14.56%
EPS
-0.87
0.32
-
2.64
2.68
-1.49%
4.05
1.33
204.51%
1.41
2.48
-43.15%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
770.25
751.59
747.45
577.21
689.31
898.57
814.64
798.44
546.89
407.13
344.64
Net Sales Growth
2.48%
0.55%
29.49%
-16.26%
-23.29%
10.30%
2.03%
46.00%
34.33%
18.13%
 
Cost Of Goods Sold
382.12
401.32
390.98
329.71
439.97
612.26
391.13
358.93
237.18
152.77
132.01
Gross Profit
388.13
350.26
356.47
247.49
249.34
286.31
423.52
439.51
309.72
254.37
212.63
GP Margin
50.39%
46.60%
47.69%
42.88%
36.17%
31.86%
51.99%
55.05%
56.63%
62.48%
61.70%
Total Expenditure
619.63
634.26
629.11
470.56
565.99
740.93
617.50
595.70
391.17
303.70
273.42
Power & Fuel Cost
-
7.13
8.25
8.14
5.88
4.76
5.49
5.58
4.72
4.36
2.93
% Of Sales
-
0.95%
1.10%
1.41%
0.85%
0.53%
0.67%
0.70%
0.86%
1.07%
0.85%
Employee Cost
-
86.17
76.15
68.09
53.69
42.32
69.23
61.35
33.74
29.43
23.46
% Of Sales
-
11.47%
10.19%
11.80%
7.79%
4.71%
8.50%
7.68%
6.17%
7.23%
6.81%
Manufacturing Exp.
-
12.24
12.09
7.83
7.07
4.95
4.88
5.39
25.65
29.98
41.44
% Of Sales
-
1.63%
1.62%
1.36%
1.03%
0.55%
0.60%
0.68%
4.69%
7.36%
12.02%
General & Admin Exp.
-
16.50
15.03
12.03
13.27
17.05
39.48
36.36
24.68
17.07
15.16
% Of Sales
-
2.20%
2.01%
2.08%
1.93%
1.90%
4.85%
4.55%
4.51%
4.19%
4.40%
Selling & Distn. Exp.
-
63.95
67.18
31.35
28.83
34.72
62.09
92.46
42.51
47.05
35.12
% Of Sales
-
8.51%
8.99%
5.43%
4.18%
3.86%
7.62%
11.58%
7.77%
11.56%
10.19%
Miscellaneous Exp.
-
46.96
59.43
13.40
17.28
24.86
45.21
35.63
22.71
23.03
35.12
% Of Sales
-
6.25%
7.95%
2.32%
2.51%
2.77%
5.55%
4.46%
4.15%
5.66%
6.76%
EBITDA
150.62
117.33
118.34
106.65
123.32
157.64
197.14
202.74
155.72
103.43
71.22
EBITDA Margin
19.55%
15.61%
15.83%
18.48%
17.89%
17.54%
24.20%
25.39%
28.47%
25.40%
20.67%
Other Income
28.73
17.79
31.49
21.95
39.19
37.63
26.54
12.51
24.35
20.29
28.00
Interest
6.91
10.36
4.74
7.24
7.57
4.41
22.80
19.69
18.61
16.41
17.98
Depreciation
26.38
18.67
17.33
17.23
12.59
8.94
21.38
20.14
13.26
11.30
10.68
PBT
116.87
106.07
127.76
104.13
142.35
181.92
179.49
175.40
148.19
96.02
70.56
Tax
35.30
29.34
31.04
30.16
33.71
55.25
56.63
62.72
48.05
34.63
29.53
Tax Rate
30.20%
27.66%
57.30%
28.96%
26.14%
30.37%
38.98%
35.76%
32.42%
36.07%
41.85%
PAT
81.58
70.85
15.04
68.49
97.26
123.72
58.78
82.04
82.49
59.91
40.99
PAT before Minority Interest
75.46
76.73
23.13
73.97
95.25
126.66
88.66
112.68
100.15
61.39
41.03
Minority Interest
-6.12
-5.88
-8.09
-5.48
2.01
-2.94
-29.88
-30.64
-17.66
-1.48
-0.04
PAT Margin
10.59%
9.43%
2.01%
11.87%
14.11%
13.77%
7.22%
10.28%
15.08%
14.72%
11.89%
PAT Growth
6.31%
371.08%
-78.04%
-29.58%
-21.39%
110.48%
-28.35%
-0.55%
37.69%
46.16%
 
EPS
7.79
6.77
1.44
6.54
9.29
11.82
5.61
7.84
7.88
5.72
3.91

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
883.90
818.70
808.25
735.61
646.00
536.24
486.62
412.62
337.08
286.88
Share Capital
10.42
10.37
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
Total Reserves
864.59
798.40
788.10
725.30
635.68
525.92
476.31
402.31
326.77
276.57
Non-Current Liabilities
42.84
29.20
45.24
46.32
37.99
12.92
32.81
49.55
67.52
95.65
Secured Loans
40.69
23.22
32.60
37.24
32.54
5.92
25.58
29.62
55.03
78.80
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
8.62
2.23
8.79
Long Term Provisions
2.69
1.07
2.50
2.44
1.75
1.91
2.05
1.81
1.40
1.10
Current Liabilities
193.26
233.09
203.64
230.53
207.03
299.40
437.09
378.97
242.68
307.66
Trade Payables
86.39
92.61
74.22
89.92
78.88
58.43
98.25
108.49
80.33
82.35
Other Current Liabilities
54.86
67.85
53.69
57.21
50.24
124.46
99.93
52.76
70.30
42.12
Short Term Borrowings
46.01
60.70
65.04
66.39
64.30
105.66
187.47
62.12
61.04
57.05
Short Term Provisions
6.00
11.93
10.69
17.01
13.61
10.85
51.45
155.60
31.00
126.14
Total Liabilities
1,153.53
1,108.75
1,076.79
1,027.22
904.88
860.04
1,022.90
874.24
662.17
700.35
Net Block
378.05
280.76
233.72
240.97
144.97
136.48
303.86
225.25
234.38
213.31
Gross Block
458.74
343.41
285.10
276.07
169.89
157.47
326.83
300.74
293.82
262.45
Accumulated Depreciation
80.69
62.65
51.38
35.10
24.92
20.99
22.97
75.48
59.44
49.14
Non Current Assets
456.15
331.89
311.59
257.48
211.39
170.25
456.97
291.23
244.66
229.67
Capital Work in Progress
2.80
22.15
2.39
0.00
46.74
0.47
4.03
9.10
0.00
4.33
Non Current Investment
2.84
2.39
0.70
0.72
0.72
6.30
1.05
0.11
0.01
0.01
Long Term Loans & Adv.
17.62
24.42
12.63
14.56
18.63
26.72
11.45
56.77
10.27
12.02
Other Non Current Assets
54.16
1.47
62.15
1.24
0.33
0.29
136.58
0.00
0.00
0.00
Current Assets
697.37
776.86
765.20
769.74
693.49
689.79
565.93
583.00
417.08
469.26
Current Investments
4.96
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
103.06
123.94
98.93
74.14
77.37
59.03
49.30
38.67
33.70
32.53
Sundry Debtors
385.17
392.75
463.82
547.91
460.73
298.48
254.45
300.93
247.47
215.03
Cash & Bank
102.99
177.53
144.55
103.32
106.63
88.86
150.50
78.18
57.29
80.37
Other Current Assets
101.19
14.12
17.55
16.13
48.76
243.41
111.68
165.22
78.62
141.34
Short Term Loans & Adv.
94.56
68.52
40.35
28.24
22.55
146.30
78.44
149.92
60.69
130.30
Net Current Assets
504.11
543.77
561.56
539.21
486.47
390.39
128.84
204.03
174.40
161.60
Total Assets
1,153.52
1,108.75
1,076.79
1,027.22
904.88
860.04
1,022.90
874.23
662.17
700.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
34.31
135.48
63.97
46.70
39.95
17.64
289.47
112.95
48.94
41.15
PBT
106.07
127.76
104.13
128.97
181.91
179.49
175.40
148.19
96.02
70.56
Adjustment
57.92
-31.71
46.29
26.85
-10.97
17.55
36.24
18.18
22.48
24.11
Changes in Working Capital
-85.12
73.37
-57.89
-70.32
-183.07
-140.80
113.48
-8.33
-60.94
-19.30
Cash after chg. in Working capital
78.87
169.42
92.53
85.49
-12.13
56.24
325.13
158.05
57.56
75.36
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-44.56
-33.94
-28.56
-38.79
52.08
-38.61
-35.66
-45.10
-8.63
-34.21
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-7.75
-92.98
-46.99
-47.89
-73.52
50.24
-231.25
-49.84
-38.98
-10.90
Net Fixed Assets
-96.13
-78.37
-10.99
-65.98
-52.48
-1.04
42.08
-5.32
-28.78
-12.86
Net Investments
0.00
0.73
0.01
0.01
0.16
2.37
-0.95
-1.36
0.00
-0.01
Others
88.38
-15.34
-36.01
18.08
-21.20
48.91
-272.38
-43.16
-10.20
1.97
Cash from Financing Activity
-24.94
-23.73
-20.80
-6.30
16.83
-75.98
-10.13
-40.25
-43.26
-8.47
Net Cash Inflow / Outflow
1.62
18.78
-3.82
-7.50
-16.74
-8.10
48.09
22.85
-33.31
21.77
Opening Cash & Equivalents
21.99
13.13
15.34
15.04
36.95
47.41
0.00
5.09
49.57
27.79
Closing Cash & Equivalent
25.01
21.99
13.13
15.34
15.04
36.95
47.41
27.60
16.26
49.57

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
84.01
78.01
77.41
71.32
62.63
51.99
47.18
40.00
32.64
27.67
ROA
6.78%
2.12%
7.03%
9.86%
14.35%
9.42%
11.88%
13.04%
9.01%
6.46%
ROE
9.11%
2.88%
9.64%
13.79%
21.43%
17.34%
25.06%
26.73%
19.74%
15.17%
ROCE
12.22%
6.37%
12.49%
17.02%
26.58%
24.61%
31.06%
32.07%
23.57%
20.56%
Fixed Asset Turnover
1.87
2.38
2.06
3.09
5.49
3.37
2.56
1.85
1.47
1.48
Receivable days
188.89
209.14
319.89
267.05
154.20
123.80
126.33
182.13
206.07
241.81
Inventory Days
55.12
54.42
54.72
40.11
27.70
24.25
20.01
24.04
29.51
34.22
Payable days
81.40
77.87
90.85
56.62
35.01
51.74
67.63
95.25
108.77
148.76
Cash Conversion Cycle
162.62
185.69
283.75
250.53
146.89
96.31
78.70
110.92
126.81
127.26
Total Debt/Equity
0.11
0.13
0.15
0.16
0.16
0.22
0.46
0.32
0.47
0.60
Interest Cover
11.23
12.42
15.38
18.04
42.21
7.37
9.91
8.96
6.85
4.92

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.